Infliximab for medical induction of remission in Crohn's disease-Reference-Cited by-同舟云学术

Infliximab for medical induction of remission in Crohn's disease

Published:2023-11-20 Issue:12 Volume:2023 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Gordon Morris¹,Sinopoulou Vassiliki¹,Akobeng Anthony K²,Radford Shellie J³,Eldragini Mohsen³,Darie Ana-Maria³,Moran Gordon William⁴

Affiliation:

1. School of Medicine; University of Central Lancashire; Preston UK

2. Pediatric Gastroenterology; Sidra Medicine; Doha Qatar

3. NIHR Nottingham Biomedical Research Centre – Gastrointestinal and Liver disorders theme; Nottingham University Hospitals NHS Trust; Nottingham UK

4. National Institute of Health Research Nottingham Biomedical Research Centre; University of Nottingham and Nottingham University Hospitals; Nottingham UK

Publisher

Wiley

Subject

Pharmacology (medical)

Reference113 articles.

1. Randomised clinical trial: deep remission in biologic and immunomodulator naive patients with Crohn's disease – a SONIC post hoc analysis;Colombel;Alimentary Pharmacology & Therapeutics,2015

2. SONIC: a randomized, double-blind, controlled trial comparing infliximab and infliximab plus azathioprine to azathioprine in patients with Crohn's disease naive to immunomodulators and biologic therapy;Colombel;Journal of Crohn's and Colitis,2009

3. Infliximab, azathioprine, or combination therapy for Crohn's disease;Colombel;New England Journal of Medicine,2010

4. Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn's disease in the SONIC trial;Peyrin-Biroulet;Gut,2014

5. Relationships between clinical remission, C-reactive protein normalization and mucosal healing in Crohn's disease: analyses from the SONIC trial;Peyrin-Biroulet;Journal of Crohn's and Colitis,2013